An international research group led by Karolinska Institutet in Sweden conducted a study to assess the effectiveness of an AI-based risk model for identifying women at high risk of breast cancer during mammography screening examinations.
The study aimed to determine if the AI model, which analyzes subtle changes in mammographic images, could work effectively across different European countries.
AI-based risk model, which evaluates mammographic images, can identify women at high risk of breast cancer based on tiny changes in the images not visible to the human eye.
Unlike traditional models that consider factors like genetics and family history, the AI model assesses thousands of image-related factors.
The researchers tested the AI model on more than 8,500 women in Italy, Spain, and Germany. The results indicated that the model worked well in different populations across Europe, suggesting its effectiveness in identifying high-risk individuals.
The AI-based risk model offers the potential for personalized breast cancer screening by identifying women who may benefit from additional examinations beyond standard mammography. This personalized approach aims to detect tumors at an earlier stage, potentially improving outcomes.
The AI model identified a group of women with almost seven times the risk of developing breast cancer compared to the normal population. These high-risk individuals may benefit from tailored screening strategies.
Breast cancer screening programs traditionally follow fixed age and time intervals. However, individual risk factors can vary significantly.
The AI-based risk model provides a promising approach to identify high-risk individuals and offer them personalized screening strategies. The study’s success in multiple European countries suggests its potential applicability in diverse populations.
If you care about breast cancer, please read studies about a major cause of deadly breast cancer, and common blood pressure drugs may increase death risk in breast cancer.
For more cancer information, please see recent studies that new cancer treatment could reawaken the immune system, and results showing vitamin D can cut cancer death risk.
The research findings can be found in The Lancet Regional Health—Europe.
Copyright © 2023 Knowridge Science Report. All rights reserved.
